P/R= 1.21
P/CF=13.1
P/E= 4.8
CR= 4.05
Net Profit Margin= 25.05%
Yield= 3.52%
Source: T1
Builds machines that carry out automated manufacturing.
Highly levered to cyclicality of semi manufacturing industry but has made several acquisitions since 2011 to enter/expand into the life sciences business.
Life Science business supports pharm/ biotech companies primarily by providing them with machines to better store biological material for testing/ accurate sample retrieval in storage.
Revs from Life Sciences increased from 2% in 2011 to 10% in 2012.
EPS earnings beat last quarter with -.06 vs -.09 consensus. Analysts have them going to EPS of $.10 in Q2.
Thoughts? Considerations? Anybody cover them?
Et consectetur velit explicabo temporibus. Ipsam voluptatem quis dolor eos necessitatibus dignissimos debitis et. Ea molestias sint voluptatibus quod. Reiciendis et et ad.
Modi quas deserunt praesentium perferendis est architecto. Consequatur tempore laborum dolores beatae iusto ipsam iste. Autem eos et expedita et sapiente consequatur modi.
Ratione nihil aperiam eos reiciendis porro necessitatibus non. Labore quo accusantium sunt enim facilis. Architecto iusto temporibus enim quae omnis mollitia eos aliquam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...